Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biosimilar Application Reviews May Be Growing More Challenging

Executive Summary

FDA assigns more staff to work on the four biosimilar applications that arrived after Zarxio, suggesting those reviews have been tougher.

Advertisement

Related Content

Biosimilar User Fee Negotiations Won't Start Until 2016
FDA’s Inaugural Biosimilar Review Bumpier Than First Appeared

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register